Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
about
Induction of p57(KIP2) expression by p73beta.Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domainsOncogenic Intra-p53 Family Member Interactions in Human Cancersp73 is over-expressed in vulval cancer principally as the Delta 2 isoformDeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoterp73, the "assistant" guardian of the genome?Role of p73 in malignancy: tumor suppressor or oncogene?TP53 family members and human cancers.p73 in Cancer.Comparison of radioimmuno and carbon nanotube field-effect transistor assays for measuring insulin-like growth factor-1 in a preclinical model of human breast cancerp53 Family: Role of Protein Isoforms in Human Cancer.TAp73 transcriptionally represses BNIP3 expression.Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptinThe p53 family in nervous system development and disease.UBE4B: a promising regulatory molecule in neuronal death and survival.E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasiaCellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk virusesApoptotic cell death in neuroblastoma.p53 family: Therapeutic targets in neuroblastoma.Tumor suppressive pathways in the control of neurogenesis.The TP73 complex network: ready for clinical translation in cancer?Tumor necrosis factor-alpha-induced caspase-1 gene expression. Role of p73.Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53.Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo.Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha.Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.Mutation analysis of the p73 gene in nonastrocytic brain tumours.CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.DeltaN-p73alpha accumulates in human neuroblastic tumors.Expression of p53 isoforms in squamous cell carcinoma of the head and neck.Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin.Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73.Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression.
P2860
Q24531472-9CEB3E51-DAC5-4BA4-9EB8-E162AD90E455Q24562758-E44E05F9-C7D8-47FD-8AF3-966076F47287Q26749382-3891FBF4-F2E5-4064-B826-7A730E572686Q28364918-6EEA526D-F09E-44C5-85F8-4D690376CF1BQ33790804-E9C50B9B-5917-4724-B2D4-B6DDCF0C3915Q34277205-BEB065B9-7C38-4C48-8417-027D06A498A3Q34307362-D5907E13-0357-4A75-9BCC-FC568628081DQ34541091-BE56C2BF-05AA-44BF-9EB2-DF6CEC744360Q35078717-75869F45-5569-4C76-B795-174897823074Q35103143-3B7D807F-E344-4547-BF48-07431AEB61F1Q35241200-0AF6403E-E6A5-4890-AD14-AA7C0BC133C5Q35326348-98B828C2-5B34-4DCF-B363-4AFD0849DDA7Q36182254-67E8ABF7-7567-4724-8FF8-82464751AFC0Q36288249-BA1DAB9A-BAA5-416A-9BC1-08C52BD37C1CQ36371274-4356BE05-93ED-4F9C-81F3-7C9BA721B3FFQ36443527-1FFE1E1D-DD30-4220-927B-0E11BE538F00Q36496801-FA564752-6AD1-4537-91AB-7B02B1FD7D46Q36521923-F5FD8C8D-1FE6-458E-B235-C43F29633442Q36538525-AB7F8DD7-F9D4-413D-97EF-C68E41BF1217Q36643752-DF645824-A41B-48D9-ACF1-927D51ACCFFCQ36989890-2045FDAF-72C1-4B0B-B1B9-26DD958B8562Q37679253-9A64D95B-4E79-4233-88B1-757AC8B54798Q37707387-2C499894-F53A-4666-A947-E03CB47D8D09Q38026794-02315F88-D3E6-4AEE-BDF4-86BA09A9FF7CQ38126476-BEB7AE68-0426-4323-A341-FA764E5215ADQ38298822-A7B497F3-ED2E-4BF0-A158-4AC9A0E179BBQ39340920-D732506B-CE90-4249-8991-64FD5B2AD836Q40150667-3DBF611A-03CD-4AF5-9C07-B768C8F295AFQ40426270-967C552F-39FF-441C-97F3-B63011A58D4AQ40474411-FBC331F7-834C-4D25-AEAF-4393D7EBCB7EQ40729038-B0A3229A-BD3B-4AB7-89FC-3FB9905F55FEQ41837471-4C1FD20E-5323-419D-87A2-76B6A6030EA7Q41876841-D0E8C4F2-26EF-4B26-97BC-35678B3F36DDQ41953887-4A95EF8D-A4A4-40BF-92ED-0A605AFD0222Q42163174-2F0E3B56-AF84-4E82-AE1C-55E1CCCA4DBEQ42412666-FDD8A64E-9DBB-46F8-830F-26D8695C997CQ42526350-62075E17-A364-49AF-A627-0FA4B5064D3AQ42718037-02CC52D8-144A-482F-B5DD-226B0D48A4F7Q44124982-76AB0744-EE28-4656-B620-5D06FA7B1BFDQ44656396-E96BADFC-11E2-4DE8-AB38-0E9DDD83468F
P2860
Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Transactivation-deficient p73a ...... optosis and competes with p53.
@en
type
label
Transactivation-deficient p73a ...... optosis and competes with p53.
@en
prefLabel
Transactivation-deficient p73a ...... optosis and competes with p53.
@en
P2093
P2860
P356
P1433
P1476
Transactivation-deficient p73a ...... optosis and competes with p53.
@en
P2093
I Fillippovich
K K Khanna
M A McGuckin
N Sorokina
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204118
P407
P577
2001-01-01T00:00:00Z
P5875
P6179
1045087741